PERFORMANCE / SINGLE
CEREBROLYSIN (6 VIALS)
60MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A peptide preparation studied for neurotrophic-signalling research, discussed in relation to endogenous factors such as NGF and BDNF.
Available Strengths
- 60MG (CBL60)
Research Protocol
Reference titration (dose shown per injection)
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Week 1 (once daily) | 20 mg | 100 | 1 mL |
| Week 2 (twice daily) | 12 mg | 60 | 0.6 mL |
| Week 3 (twice daily) | 14 mg | 70 | 0.7 mL |
| Weeks 4+ (twice daily) | 16 mg | 80 | 0.8 mL |
Reconstitution
20 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 60 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Described in the cited source as crossing the blood-brain barrier and modulating neuroinflammatory pathways in neuronal-survival research.
Storage
Room temperature ≤25°C, dry conditions. 2–8°C, use within 7 days, do not freeze.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source